177 related articles for article (PubMed ID: 2120136)
1. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
[TBL] [Abstract][Full Text] [Related]
2. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.
Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F
J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants.
Bianchi R; Fioretti MC; Grohmann U; Binaglia L; Romani L; Puccetti P
Int J Immunopharmacol; 1992 Jul; 14(5):915-21. PubMed ID: 1512082
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant.
Romani L; Grohmann U; Puccetti P; Nardelli B; Mage MG; Fioretti MC
Cell Immunol; 1988 Feb; 111(2):365-78. PubMed ID: 3123072
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant.
Bianchi R; Romani L; Puccetti P; Fioretti MC
Int J Cancer; 1988 Jul; 42(1):71-5. PubMed ID: 2968958
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
8. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
Awwad M; North RJ
J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
[TBL] [Abstract][Full Text] [Related]
9. The mode of recognition of tumor antigens by noncytolytic-type antitumor T cells: role of antigen-presenting cells and their surface class I and class II H-2 molecules.
Sakamoto K; Nakajima H; Shimizu J; Katagiri T; Kiyotaki C; Fujiwara H; Hamaoka T
Cancer Immunol Immunother; 1988; 27(3):261-6. PubMed ID: 3141057
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
Mizuochi T; Ono S; Malek TR; Singer A
J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells.
Romani L; Grohmann U; Puccetti P; Rossi MA; Fioretti MC
Int J Immunopharmacol; 1990; 12(7):743-9. PubMed ID: 2292454
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes.
Ransom J; Fischer M; Mosmann T; Yokota T; DeLuca D; Schumacher J; Zlotnik A
J Immunol; 1987 Dec; 139(12):4102-8. PubMed ID: 3121729
[TBL] [Abstract][Full Text] [Related]
13. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
15. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells.
Hochgeschwender U; Diamantstein T; Prester M; Nerz G; Simon MM
Immunobiology; 1986 Apr; 171(3):274-301. PubMed ID: 3086217
[TBL] [Abstract][Full Text] [Related]
17. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.
Sprent J; Schaefer M
J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
19. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of Ia antigen-bearing keratinocytes: mixed skin lymphocyte culture between Ia antigen-bearing Pam 212 cells and allogeneic and syngeneic splenic T cells.
Aiba S; Tagami H
J Invest Dermatol; 1987 Dec; 89(6):560-6. PubMed ID: 3119731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
